Try our Advanced Search for more refined results
Competition
-
January 27, 2026
Mylan's Sanofi Insulin Suit Mostly Survives Dismissal Bid
A Pennsylvania federal judge Tuesday largely refused to dismiss Mylan Pharmaceuticals' antitrust lawsuit accusing Sanofi of unlawfully maintaining a monopoly in the market for injectable insulin glargine.
-
January 27, 2026
AGs' HPE-Juniper Hold Too Broad, Too Late, Judge Says
A California federal judge explained his reasoning for refusing to block further integration between Hewlett Packard Enterprise and Juniper Networks, while Democratic attorneys general challenge the Justice Department's controversial settlement permitting the merger.
-
January 27, 2026
Colo. Atty Says Former Mentee Poached Clients
A Colorado attorney told a state court that a former associate he mentored for several years secretly solicited firm clients, misused confidential information and set up a competing practice while still employed.
-
January 27, 2026
Homebuyers Say Rocket Mortgage Illegally Inflated Prices
A proposed class of homebuyers accused Rocket Companies Inc. and its subsidiaries in Michigan federal court of illegally hiking home prices by sending business leads to real estate agents who pushed clients to use Rocket's "disadvantageous" financing services for purchases.
-
January 27, 2026
EU Advances Brookfield, GIC's Australian Storage REIT Buy
European regulators on Tuesday signed off on a proposed $2.6 billion buyout of Australian self-storage company National Storage REIT by Brookfield Asset Management and GIC, in a deal advised by Ashurst LLP and Clayton Utz.
-
January 27, 2026
NRG, LS Power's $12B Natural Gas Deal Clears DOJ Scrutiny
The U.S. Department of Justice has cleared NRG Energy Inc.'s $12 billion acquisition of 18 natural gas-fired power plants from LS Power in a cash-and-stock deal guided by White & Case LLP, Milbank LLP and Willkie Farr & Gallagher LLP.
-
January 27, 2026
CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines
The Competition and Markets Authority sought permission from the Court of Appeal on Tuesday to challenge a decision that criticized and revised the £70 million ($96 million) in fines it issued to Pfizer and Flynn Pharma for excessive pricing.
-
January 27, 2026
Poultry Cos. Told To Stay Separate Amid UK Antitrust Probe
Britain's antitrust enforcer told Société LDC SA of France and Gressingham Foods, a breeder of ducks in England, on Tuesday not to integrate their poultry businesses as it carries out an investigation into the deal, which was completed in December.
-
January 26, 2026
Mich. AG's Antitrust Suit Charts New Path For Climate Torts
Michigan Attorney General Dana Nessel's antitrust lawsuit against fossil fuel companies opens a new front in climate change tort litigation, and is a riposte to red states using antitrust law to target pro-climate actions by companies.
-
January 26, 2026
Senate Antitrust Chair Flags Concerns In Netflix-Warner Deal
Netflix's proposed $82.7 billion purchase of Warner Bros. Discovery's studios and HBO streaming businesses risks being a "killer non-acquisition," Sen. Mike Lee has reportedly told the media giants' chief executives, expressing concern that a likely lengthy merger review could leave Warner Bros. in a weakened state.
-
January 26, 2026
Justices Urged To Keep Baseball's Antitrust Shield In Play
Puerto Rico's professional baseball league on Monday urged the U.S. Supreme Court not to disturb the sport's century-old exemption from antitrust law, arguing that the justices have rejected similar challenges to the shield time and time again.
-
January 26, 2026
Southern Glazer's Wants To Compare FTC Case To Kroger
Southern Glazer's Wine and Spirits LLC urged a California federal judge Friday to give it key material from the Federal Trade Commission's successful challenge to the Kroger-Albertsons merger, sparring with the FTC on arguments that the agency is contradicting itself in a price discrimination lawsuit.
-
January 26, 2026
Generics Makers Fight Cert. In Cholesterol Drug Pricing MDL
Generic-drug makers sought to defeat a bid to certify proposed classes comprising thousands of pharmacies that indirectly purchased and resold generics at the center of sprawling price-fixing litigation, telling a Pennsylvania federal court Monday that certification would result in an "unmanageable trial."
-
January 26, 2026
Truck Makers Say Calif. Delaying 'Clean Trucks Pact' Fight
Heavy-duty truck manufacturers on Monday accused California officials of trying to delay litigation over a 2023 agreement that would saddle manufacturers with stringent state emissions standards and stiff penalties for noncompliance in the coming years.
-
January 26, 2026
Fubo Subscribers Defend Streaming Rate Suit Against Disney
A proposed class of Fubo subscribers is opposing a bid from Disney to force them to arbitrate their claims in an antitrust case alleging streaming services pay inflated rates to carry ESPN and other sports channels.
-
January 26, 2026
Google Targets Publishers' Ad Tech Claims
Google asked a New York federal judge to cut out a wide swath of antitrust claims from multidistrict litigation targeting its advertising placement technology dominance, assailing in separate briefs allegations from a class of website publishers and from the Daily Mail and Gannett.
-
January 26, 2026
9th Circ. Pauses Discovery Order In UFC Wage Suits
A Ninth Circuit panel temporarily paused a Nevada federal court's discovery order in wage suppression lawsuits against UFC after the mixed martial arts organization said the order violated attorney-client privilege and the First Amendment.
-
January 26, 2026
Amex Seeks First Approval Of $17M Antisteering Settlement
American Express Co. has asked a New York federal judge to grant the first green light to a $17.5 million settlement reached with consumers who claimed the credit card company's so-called antisteering rules caused non-Amex cardholders to pay higher charges, after a New York federal jury ordered Amex to pay $12 million to one class of consumers.
-
January 26, 2026
Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics
A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for the GLP-1 drug Victoza.
-
January 26, 2026
Radio Co. Says Letting Nielsen Resume Data Tying Hurts Biz
Cumulus Media has urged the Second Circuit not to lift a New York federal judge's order blocking Nielsen from conditioning access to its nationwide radio ratings data on the purchase of local market data while the ratings company appeals the ruling.
-
January 26, 2026
Remote Discovery Tech Co. Alleges Fraud In Del. Suit
A tech company that developed self-service applications for remote data collection from smartphones has launched a seven-count suit in Delaware's Court of Chancery accusing a product reseller of copying the application's functions and features and marketing competing versions.
-
January 26, 2026
Calif. Gaming Org. Fights Tribe's Bid To Join $700M Casino Suit
A District of Columbia federal judge on Monday granted the California Gaming Association's amicus brief bid to oppose a California Indian tribe's potential dismissal motion against another tribe's fight with the federal government over a $700 million casino project in Vallejo, California.
-
January 23, 2026
Pro Swimming League Wins Antitrust Trial. Its Prize? $1
A California federal jury has determined that World Aquatics illegally boycotted International Swimming League events in violation of federal antitrust law, but awarded just $1 in damages, in a verdict returned Friday.
-
January 23, 2026
Mich. AG Sues Major Oil Co. 'Cartel' Amid Fight With DOJ
Michigan Attorney General Dana Nessel filed an antitrust suit in federal court against BP, Shell, Chevron, Exxon and the American Petroleum Institute on Friday, claiming they conspired to maintain market dominance by steering money away from renewable energy and using a bevy of other tactics including intimidation and information suppression.
-
January 23, 2026
CLO Investors Accused Of Rigging Rates In Shift From Libor
Major equity investors in collateralized loan obligations have been sued in Connecticut federal court over claims that they colluded to force corporate leveraged-loan borrowers to accept higher interest rates during the phaseout of the London Interbank Offered Rate, or Libor.
Expert Analysis
-
Opinion
Sometimes Int'l Competition Should Trump Antitrust Concerns
The U.S. Justice Department's approval of HPE's $14 billion acquisition of Juniper Networks shows that a merger that significantly enhances innovation and competitiveness may serve consumer and national interests despite marginally increasing industry concentration, says John Reeves at Reeves Law.
-
Series
Quilting Makes Me A Better Lawyer
Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.
-
A Look At Robinson-Patman Enforcement In The MLM Industry
The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.
-
What 2 Profs Noticed As Transactional Law Students Used AI
After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.
-
State AGs Are Turning Up The Antitrust Heat On ESG Actions
Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.
-
Rebuttal
BigLaw Settlements Should Not Spur Ethics Deregulation
A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.
-
Opinion
8th Circ. Should Reaffirm False Commercial Speech's Nature
The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.
-
How Big Pharma Has Responded To FTC Delisting Demands
Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.
-
Unpacking Ore. Law's Limits On PE Healthcare Investment
A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.
-
5 Ways Lawyers Can Earn Back The Public's Trust
Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.
-
Class Actions At The Circuit Courts: August Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.
-
Series
Hiking Makes Me A Better Lawyer
On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.
-
Series
Law School's Missed Lessons: Negotiation Skills
I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.
-
DOJ Whistleblower Program May Fuel Criminal Antitrust Tack
A recently launched Justice Department program that provides rewards for reporting antitrust crimes related to the U.S. Postal Service will serve to supplement the department’s leniency program, signaling an ambition to expand criminal enforcement while deepening collaboration across agencies, say attorneys at Crowell & Moring.
-
Opinion
Bar Exam Reform Must Expand Beyond A Single Updated Test
Recently released information about the National Conference of Bar Examiners’ new NextGen Uniform Bar Exam highlights why a single test is not ideal for measuring newly licensed lawyers’ competency, demonstrating the need for collaborative development, implementation and reform processes, says Gregory Bordelon at Suffolk University.